Loading…
Reported covered position: Staff Director, Senate Finance Committee ; ; Chief of Staff, Senator Max Baucus ; ; Deputy Asst, Special Asst, Deputy Director EOP
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: ALTRIA CLIENT SERVICES LLC · Firm: FORBES-TATE
Issues related to tobacco tax; Issues related to excise tax on tobacco in the Inflation Reduction Act of 2022 (PL 117-169); Issues related to drawback provision in H.R.1 - the One Big Beautiful Bill Act (PL 119-21).
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: ALTRIA CLIENT SERVICES LLC · Firm: FORBES-TATE
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
EDWARD D. JONES & CO., L.P. via FORBES-TATE
2026 · third_quarter · Q3
Issues related to retirement security and savings matters; Issues related to small business retirement and retirement savings; Issues related to retirement savings for military spouses; SIMPLE IRAs; Issues related to financial transactions, capital gains, and dividend income taxes; Issues related to senior investor protection matters; Issues related to SEC and DOL standard of care rulemaking; Issues related to partnership tax and IRS Code Section 199A; Issues related to state and local tax provisions for Service Business in the One Big Beautiful Bill Act (PL 119-21).
Source: Senate LDA
| CTIA - THE WIRELESSS ASSOCIATION |
| 54 |
| 2013–2026 |
| GENENTECH | 54 | 2013–2026 |
| PHRMA | 54 | 2013–2026 |
| VERIZON COMMUNICATIONS INC AND VARIOUS SUBSIDIARIES | 54 | 2013–2026 |
| ASSOCIATION OF AMERICAN RAILROADS | 50 | 2014–2026 |
| NATIONAL CABLE TELECOMMUNICATIONS ASSOCIATION | 50 | 2012–2024 |
| UNITED PARCEL SERVICE | 49 | 2012–2024 |
| AIRLINES FOR AMERICA | 47 | 2016–2026 |
| THE NATIONAL FOOTBALL LEAGUE PLAYERS ASSOCIATION | 47 | 2014–2025 |
| LUMEN TECHNOLOGIES SERVICE GROUP, LLC | 44 | 2015–2026 |
| ALTRIA CLIENT SERVICES LLC | 43 | 2016–2026 |
| NORTHWESTERN ENERGY | 41 | 2013–2023 |
| HCR MANORCARE | 40 | 2013–2022 |
| IRON MOUNTAIN INFORMATION MANAGEMENT, LLC | 40 | 2017–2026 |
| ORACLE | 40 | 2013–2023 |
| PACIFIC GAS AND ELECTRIC | 38 | 2013–2022 |
| ANNALY CAPITAL MANAGEMENT, INC. | 35 | 2013–2021 |
| NOVARTIS, INC. | 35 | 2019–2026 |
| COMCAST CORPORATION | 33 | 2012–2020 |
| INSURED RETIREMENT INSTITUTE | 32 | 2019–2026 |
| SANOFI U.S. | 32 | 2019–2026 |
| WE ARE GOLF | 31 | 2013–2021 |
| ANHEUSER-BUSCH COMPANIES, INC. | 30 | 2013–2020 |
| WALGREENS CO. | 30 | 2018–2025 |
| CAPITOL SOLUTIONS ON BEHALF OF BIPARTISAN POLICY CENTER ADVOCACY NETWORK, INC. | 29 | 2015–2022 |
| ALEXION PHARMACEUTICALS, INC. | 28 | 2020–2026 |
| ASSURED GUARANTY MUNICIPAL CORP. | 28 | 2019–2025 |
| BANK OF AMERICA CORPORATION | 28 | 2015–2022 |
| COALITION FOR CANNABIS POLICY, EDUCATION, AND REGULATION | 28 | 2021–2026 |
| ADVANCED MICRO DEVICES (AMD) | 27 | 2020–2026 |
| GRAIL, Inc. | 27 | 2020–2026 |
| H&R BLOCK | 27 | 2013–2019 |
| TYSON SHARED SERVICES, INC. | 27 | 2020–2026 |
| GOBRANDS, INC. | 25 | 2020–2026 |
| LILLY USA, LLC | 25 | 2020–2025 |
| PELOTON INTERACTIVE, INC. | 25 | 2021–2026 |
| UNIVERSAL MUSIC GROUP RECORDINGS, INC. | 25 | 2020–2026 |
| ACTIVEHOURS INC., D/B/A EARNIN | 23 | 2021–2026 |
| DELOITTE LLP | 23 | 2018–2023 |
| GILEAD SCIENCES, INC. | 23 | 2020–2025 |
| HALOZYME THERAPEUTICS, INC. | 22 | 2019–2026 |
| JOBSOHIO | 21 | 2021–2026 |
| EDWARD D. JONES & CO., L.P. | 19 | 2022–2026 |
| ABBOTT LABORATORIES | 18 | 2016–2020 |
| U.S. BEET SUGAR ASSOCIATION (USBSA) | 18 | 2021–2025 |
| BAYER CORPORATION | 17 | 2019–2022 |
| HORIZON THERAPEUTICS | 17 | 2020–2023 |
| UNITED AIRLINES, INC | 17 | 2018–2021 |
| BROADCOM LIMITED | 16 | 2018–2021 |
| LUNDBECK LLC | 16 | 2017–2021 |
| WITH HONOR ACTION | 16 | 2019–2023 |
| INTERNATIONAL COUNCIL OF SHOPPING CENTERS | 15 | 2020–2023 |
| NATIONAL HOCKEY LEAGUE | 15 | 2018–2021 |
| SONY INTERACTIVE ENTERTAINMENT LLC | 15 | 2022–2026 |
| TRACTOR SUPPLY CO. | 15 | 2023–2026 |
| CRITEO CORPORATION | 14 | 2020–2023 |
| INTERNET TAX FREEDOM ACT COALITION | 14 | 2013–2016 |
| SECURITIES INDUSTRY AND FINANCIAL MARKETS ASSOCIATION | 14 | 2015–2018 |
| VISA U.S.A. INC. | 14 | 2023–2026 |
| AMERICAN INDEPENDENT MEDICAL PRACTICE ASSOCIATION | 13 | 2023–2026 |
| COMMUNITY FINANCIAL SERVICES ASSOCIATION | 13 | 2013–2015 |
| EYEPOINT PHARMACEUTICALS, INC. | 13 | 2020–2022 |
| GLOBAL MEDICAL RESPONSE | 13 | 2022–2024 |
| HESS CORPORATION | 13 | 2015–2017 |
| TRUE VELOCITY | 13 | 2019–2021 |
| LYKOS THERAPEUTICS | 12 | 2023–2024 |
| PRIMMUNE THERAPEUTICS | 12 | 2020–2022 |
| RTX CORPORATION | 12 | 2024–2026 |
| SPOTIFY USA INC. | 12 | 2015–2017 |
| THE PARTNERSHIP FOR AMERICAS HEALTH CARE FUTURE | 12 | 2019–2021 |
| ALLERGAN USA, INC. | 11 | 2013–2015 |
| AMERICAN COUNCIL OF LIFE INSURERS | 11 | 2012–2015 |
| INDEPENDENT PHARMACY COOPERATIVE | 11 | 2016–2018 |
| NEW VENTURE FUND ON BEHALF OF CENTER FOR SECURE AND MODERN ELECTIONS | 11 | 2021–2023 |
| REFORMING AMERICA'S TAXES EQUITABLY | 11 | 2021–2023 |
| SCANA CORPORATION | 11 | 2013–2015 |
| BAE SYSTEMS, INC. | 10 | 2018–2020 |
| CELLEBRITE INC | 10 | 2017–2019 |
| COMMERCIAL REAL ESTATE FINANCIAL COUNCIL | 10 | 2016–2018 |
| DS ADMIRAL BIDCO, LLC | 10 | 2023–2024 |
| ROUNDTABLE ON SUSTAINABLE PALM OIL | 10 | 2021–2022 |
| TARGET CORPORATION | 10 | 2020–2022 |
| UBER TECHNOLOGIES INC. | 10 | 2024–2026 |
| CAUTHEN FORBES & WILLIAMS ON BEHALF OF AMAZON.COM | 9 | 2012–2014 |
| MONUMENTAL SPORTS | 9 | 2024–2026 |
| STANDARD INDUSTRIES, INC. | 9 | 2020–2021 |
| DIGESTIVE HEALTH PHYSICIANS ASSOCIATION | 8 | 2025–2026 |
| UNITEDHEALTH GROUP | 8 | 2013–2015 |
| BLOCKCHAIN ASSOCIATION | 7 | 2022–2023 |
| CISCO SYSTEMS, INC. | 7 | 2013–2014 |
| EVOLUS BEAUTY | 7 | 2019–2020 |
| ROBERTI GLOBAL, LLC ON BEHALF OF ASSURED GUARANTY MUNICIPAL CORP. | 7 | 2018–2019 |
| SHEIN TECHNOLOGY LLC | 7 | 2024–2025 |
| UNDER ARMOUR, INC. | 7 | 2017–2018 |
Issues related to tobacco tax; Issues related to excise tax on tobacco in the Inflation Reduction Act of 2022 (PL 117-169); Issues related to drawback provision in H.R.1 - the One Big Beautiful Bill Act (PL 119-21).
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: ALTRIA CLIENT SERVICES LLC · Firm: FORBES-TATE
Issues related to tobacco tax; Issues related to excise tax on tobacco in the Inflation Reduction Act of 2022 (PL 117-169); Issues related to drawback provision in H.R.1 - the One Big Beautiful Bill Act (PL 119-21).
Retirement Fairness for Charities and Educational Institutions Act of 2025
Client: INSURED RETIREMENT INSTITUTE · Firm: FORBES-TATE
Issues related to retirement savings; Issues related to H.R. 1013/S. 424 - The Retirement Fairness for Charities and Educational Institutions Act of 2025; Issues related to DOL Fiduciary rule.
Retirement Fairness for Charities and Educational Institutions Act of 2025
Client: INSURED RETIREMENT INSTITUTE · Firm: FORBES-TATE
Issues related to retirement savings; Issues related to H.R. 1013/S. 424 - The Retirement Fairness for Charities and Educational Institutions Act of 2025; Issues related to DOL Fiduciary rule.
Issues related to prescription drug pricing; Issues related to Medicare, Medicaid, Cell and Gene Therapies; Issues regarding the 340B Drug Pricing Program; Issues related to the implementation of Consolidated Appropriations Act, 2024 (PL 118-42); Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); H.R. 1672 - Maintaining Investments in New Innovation Act; Issues related to Most Favored Nation policy; H.R. 3037/S. 1500 - Access to Breast Cancer Diagnosis Act of 2025.
Issues related to prescription drug pricing; Issues related to Medicare, Medicaid, Cell and Gene Therapies; Issues regarding the 340B Drug Pricing Program; Issues related to the implementation of Consolidated Appropriations Act, 2024 (PL 118-42); Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); H.R. 1672 - Maintaining Investments in New Innovation Act; Issues related to Most Favored Nation policy; H.R. 3037 / S. 1500 Access to Breast Cancer Diagnostic Act of 2025.
Issues related to prescription drug pricing; Issues related to Medicare, Medicaid, Cell and Gene Therapies; Issues regarding the 340B Drug Pricing Program; Issues related to the implementation of Consolidated Appropriations Act, 2024 (PL 118-42); Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); H.R. 1672 - Maintaining Investments in New Innovation Act; Issues related to Most Favored Nation policy; H.R. 3037 / S. 1500 Access to Breast Cancer Diagnosis Act of 2025.
Issues related to prescription drug pricing; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to pharmacy benefit managers; H.R. 1672 - Maintaining Investments in New Innovation Act; Issues related to the 340b program; Issues related to S. 832 - EPIC Act of 2025.
Issues related to prescription drug pricing; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to pharmacy benefit managers; H.R. 1672 - Maintaining Investments in New Innovation Act; Issues related to the 340b program; Issues related to S. 832 - EPIC Act of 2025.
Issues related to prescription drug pricing; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to pharmacy benefit managers; H.R. 1672 - Maintaining Investments in New Innovation Act; Issues related to the 340b program; Issues related to S. 832 - EPIC Act of 2025.
Combating Organized Retail Crime Act of 2025
Client: ASSOCIATION OF AMERICAN RAILROADS · Firm: FORBES-TATE
Issues related to preserving economic balance regarding regulation of the railroad industry; Issues related to two-man crew sites; Issues related to infrastructure and transportation; Issues related to safety requirements for rail carriers and trains transporting hazardous materials; Issues related to H.R. 2853/S. 1404 - Combating Organized Retail Crime Act.
Combating Organized Retail Crime Act of 2025
Client: ASSOCIATION OF AMERICAN RAILROADS · Firm: FORBES-TATE
Issues related to preserving economic balance regarding regulation of the railroad industry; Issues related to two-man crew sites; Issues related to infrastructure and transportation; Issues related to safety requirements for rail carriers and trains transporting hazardous materials; Issues related to H.R. 2853/S. 1404 - Combating Organized Retail Crime Act of 2025.
Combating Organized Retail Crime Act of 2025
Client: ASSOCIATION OF AMERICAN RAILROADS · Firm: FORBES-TATE
Issues related to preserving economic balance regarding regulation of the railroad industry; Issues related to two-man crew sites; Issues related to infrastructure and transportation; Issues related to safety requirements for rail carriers and trains transporting hazardous materials; Issues related to H.R. 2853/S. 1404 - Combating Organized Retail Crime Act.
Issues related to prescription drug pricing; Issues related to Medicare, Medicaid, Cell and Gene Therapies; Issues regarding the 340B Drug Pricing Program; Issues related to the implementation of Consolidated Appropriations Act, 2024 (PL 118-42); Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); H.R. 1672 - Maintaining Investments in New Innovation Act; Issues related to Most Favored Nation policy; H.R. 3037 / S. 1500 Access to Breast Cancer Diagnostic Act of 2025.
Issues related to prescription drug pricing; Issues related to Medicare, Medicaid, Cell and Gene Therapies; Issues regarding the 340B Drug Pricing Program; Issues related to the implementation of Consolidated Appropriations Act, 2024 (PL 118-42); Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); H.R. 1672 - Maintaining Investments in New Innovation Act; Issues related to Most Favored Nation policy; H.R. 3037 / S. 1500 Access to Breast Cancer Diagnosis Act of 2025.
Issues related to prescription drug pricing; Issues related to Medicare, Medicaid, Cell and Gene Therapies; Issues regarding the 340B Drug Pricing Program; Issues related to the implementation of Consolidated Appropriations Act, 2024 (PL 118-42); Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); H.R. 1672 - Maintaining Investments in New Innovation Act; Issues related to Most Favored Nation policy; H.R. 3037/S. 1500 - Access to Breast Cancer Diagnosis Act of 2025.
Issues related to the One Big Beautiful Bill Act (PL 119-21); Issues related to Tax Relief for American Families and Workers; Issues related to H.R. 5099 - SAFES Act.
One Big Beautiful Bill Act (PL 119-21); Issues related to Tax Relief for American Families and Workers; Issues related to H.R. 5099 - SAFES Act.
Issues related to Medicare and Medicaid payments to physicians; Issues related to medical imaging; Issues related to Appropriate Use Criteria (AUC); Issues related to prior authorization in Medicare and Medicaid; Issues related to H.R. 639 - Doctor Knows Best Act of 2025; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to Consolidated Appropriations Act, 2026 (PL 119-75); Issues related to SUPPORT for Patients and Communities Reauthorization Act of 2025 (PL 119-44); Issues related to H.R. 5737/S. 1692 - Radiology Outpatient Ordering Transmission (ROOT) Act.
Issues related to Medicare and Medicaid payments to physicians; Issues related to medical imaging; Issues related to Appropriate Use Criteria (AUC); Issues related to prior authorization in Medicare and Medicaid; Issues related to H.R. 639 - Doctor Knows Best Act of 2025; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to S. 891 - Bipartisan Health Care Act; Issues related to H.R. 5737/S. 1692 - Radiology Outpatient Ordering Transmission (ROOT) Act.
Issues related to Medicare and Medicaid payments to physicians; Issues related to medical imaging; Issues related to Appropriate Use Criteria (AUC); Issues related to prior authorization in Medicare and Medicaid; Issues related to H.R. 639 - Doctor Knows Best Act of 2025; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to S. 891 - Bipartisan Health Care Act; Issues related to H.R. 5737/S. 1692 - Radiology Outpatient Ordering Transmission (ROOT) Act.
Issues related to the semiconductor industry; Issues related to trade; Issues related to manufacturing; Issues related to AI; Issues related to H.R. 5885/S. 3150 - GAIN AI Act of 2025.
Issues related to the semiconductor industry; Issues related to trade; Issues related to manufacturing; Issues related to AI; Issues related to H.R. 5885/S. 3150 - GAIN AI Act of 2025.
Issues related to the semiconductor industry; Issues related to trade; Issues related to manufacturing; Issues related to AI; Issues related to H.R. 5885/S. 3150 - GAIN AI Act of 2025.
Doctor Knows Best Act of 2025
Client: AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION · Firm: FORBES-TATE
Issues related to Medicare and Medicaid payments to physicians; Issues related to medical imaging; Issues related to Appropriate Use Criteria (AUC); Issues related to prior authorization in Medicare and Medicaid; Issues related to H.R. 639 - Doctor Knows Best Act of 2025; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to S. 891 - Bipartisan Health Care Act; Issues related to H.R. 5737/S. 1692 - Radiology Outpatient Ordering Transmission (ROOT) Act.
Doctor Knows Best Act of 2025
Client: AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION · Firm: FORBES-TATE
Issues related to Medicare and Medicaid payments to physicians; Issues related to medical imaging; Issues related to Appropriate Use Criteria (AUC); Issues related to prior authorization in Medicare and Medicaid; Issues related to H.R. 639 - Doctor Knows Best Act of 2025; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to Consolidated Appropriations Act, 2026 (PL 119-75); Issues related to SUPPORT for Patients and Communities Reauthorization Act of 2025 (PL 119-44); Issues related to H.R. 5737/S. 1692 - Radiology Outpatient Ordering Transmission (ROOT) Act.
Doctor Knows Best Act of 2025
Client: AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION · Firm: FORBES-TATE
Issues related to Medicare and Medicaid payments to physicians; Issues related to medical imaging; Issues related to Appropriate Use Criteria (AUC); Issues related to prior authorization in Medicare and Medicaid; Issues related to H.R. 639 - Doctor Knows Best Act of 2025; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to S. 891 - Bipartisan Health Care Act; Issues related to H.R. 5737/S. 1692 - Radiology Outpatient Ordering Transmission (ROOT) Act.
Issues related to payments, including in H.R. 7035 / S. 3623 - Credit Card Competition Act of 2026; Issues related to the GENIUS Act (P.L. 119-27).
Issues related to payments, including in H.R. 7035 / S. 3623 - Credit Card Competition Act; Issues related to the GENIUS Act (P.L. 119-27).
Issues related to advanced design tax credit; Issues related to H.R. 802 - STAR Act of 2025; Issues related to implementation of the CHIPS and Science Act of 2022 (PL 117-167); Issues related to research and development tax amortization fix.
Issues related to advanced design tax credit; Issues related to H.R. 802 - STAR Act of 2025; Issues related to implementation of the CHIPS and Science Act of 2022 (PL 117-167); Issues related to research and development tax amortization fix.
Issues related to advanced design tax credit; Issues related to H.R. 802 - STAR Act of 2025; Issues related to implementation of the CHIPS and Science Act of 2022 (PL 117-167); Issues related to research and development tax amortization fix.
Medicare Patient Access and Practice Stabilization Act of 2025
Client: AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION · Firm: FORBES-TATE
Issues related to the CY 2025 Medicare Physician Fee Schedule proposed rule; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to Consolidated Appropriations Act, 2026 (PL 119-75); Issues related to SUPPORT for Patients and Communities Reauthorization Act of 2025 (PL 119-44).
Medicare Patient Access and Practice Stabilization Act of 2025
Client: AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION · Firm: FORBES-TATE
Issues related to Medicare and Medicaid payments to physicians; Issues related to medical imaging; Issues related to Appropriate Use Criteria (AUC); Issues related to prior authorization in Medicare and Medicaid; Issues related to H.R. 639 - Doctor Knows Best Act of 2025; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to Consolidated Appropriations Act, 2026 (PL 119-75); Issues related to SUPPORT for Patients and Communities Reauthorization Act of 2025 (PL 119-44); Issues related to H.R. 5737/S. 1692 - Radiology Outpatient Ordering Transmission (ROOT) Act.
Medicare Patient Access and Practice Stabilization Act of 2025
Client: AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION · Firm: FORBES-TATE
Issues related to the CY 2025 Medicare Physician Fee Schedule proposed rule; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to Consolidated Appropriations Act, 2026 (PL 119-75); Issues related to SUPPORT for Patients and Communities Reauthorization Act of 2025 (PL 119-44).
Medicare Patient Access and Practice Stabilization Act of 2025
Client: AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION · Firm: FORBES-TATE
Issues related to Medicare and Medicaid payments to physicians; Issues related to medical imaging; Issues related to Appropriate Use Criteria (AUC); Issues related to prior authorization in Medicare and Medicaid; Issues related to H.R. 639 - Doctor Knows Best Act of 2025; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to S. 891 - Bipartisan Health Care Act; Issues related to H.R. 5737/S. 1692 - Radiology Outpatient Ordering Transmission (ROOT) Act.
Medicare Patient Access and Practice Stabilization Act of 2025
Client: AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION · Firm: FORBES-TATE
Issues related to the CY 2025 Medicare Physician Fee Schedule proposed rule; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to Consolidated Appropriations Act, 2026 (PL 119-75); Issues related to SUPPORT for Patients and Communities Reauthorization Act of 2025 (PL 119-44).
Medicare Patient Access and Practice Stabilization Act of 2025
Client: AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION · Firm: FORBES-TATE
Issues related to Medicare and Medicaid payments to physicians; Issues related to medical imaging; Issues related to Appropriate Use Criteria (AUC); Issues related to prior authorization in Medicare and Medicaid; Issues related to H.R. 639 - Doctor Knows Best Act of 2025; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to S. 891 - Bipartisan Health Care Act; Issues related to H.R. 5737/S. 1692 - Radiology Outpatient Ordering Transmission (ROOT) Act.
Combating Organized Retail Crime Act
Client: ASSOCIATION OF AMERICAN RAILROADS · Firm: FORBES-TATE
Issues related to preserving economic balance regarding regulation of the railroad industry; Issues related to two-man crew sites; Issues related to infrastructure and transportation; Issues related to safety requirements for rail carriers and trains transporting hazardous materials; Issues related to H.R. 2853/S. 1404 - Combating Organized Retail Crime Act of 2025.
Combating Organized Retail Crime Act
Client: ASSOCIATION OF AMERICAN RAILROADS · Firm: FORBES-TATE
Issues related to preserving economic balance regarding regulation of the railroad industry; Issues related to two-man crew sites; Issues related to infrastructure and transportation; Issues related to safety requirements for rail carriers and trains transporting hazardous materials; Issues related to H.R. 2853/S. 1404 - Combating Organized Retail Crime Act.
Combating Organized Retail Crime Act
Client: ASSOCIATION OF AMERICAN RAILROADS · Firm: FORBES-TATE
Issues related to preserving economic balance regarding regulation of the railroad industry; Issues related to two-man crew sites; Issues related to infrastructure and transportation; Issues related to safety requirements for rail carriers and trains transporting hazardous materials; Issues related to H.R. 2853/S. 1404 - Combating Organized Retail Crime Act.
Issues related to prescription drug pricing; Issues related to Medicare, Medicaid, Cell and Gene Therapies; Issues regarding the 340B Drug Pricing Program; Issues related to the implementation of Consolidated Appropriations Act, 2024 (PL 118-42); Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); H.R. 1672 - Maintaining Investments in New Innovation Act; Issues related to Most Favored Nation policy; H.R. 3037 / S. 1500 Access to Breast Cancer Diagnostic Act of 2025.
Issues related to prescription drug pricing; Issues related to Medicare, Medicaid, Cell and Gene Therapies; Issues regarding the 340B Drug Pricing Program; Issues related to the implementation of Consolidated Appropriations Act, 2024 (PL 118-42); Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); H.R. 1672 - Maintaining Investments in New Innovation Act; Issues related to Most Favored Nation policy; H.R. 3037/S. 1500 - Access to Breast Cancer Diagnosis Act of 2025.
Issues related to prescription drug pricing; Issues related to Medicare, Medicaid, Cell and Gene Therapies; Issues regarding the 340B Drug Pricing Program; Issues related to the implementation of Consolidated Appropriations Act, 2024 (PL 118-42); Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); H.R. 1672 - Maintaining Investments in New Innovation Act; Issues related to Most Favored Nation policy; H.R. 3037 / S. 1500 Access to Breast Cancer Diagnosis Act of 2025.
Medicare Patient Access and Practice Stabilization Act of 2025
Client: AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION · Firm: FORBES-TATE
Issues related to the CY 2025 Medicare Physician Fee Schedule proposed rule; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to Consolidated Appropriations Act, 2026 (PL 119-75); Issues related to SUPPORT for Patients and Communities Reauthorization Act of 2025 (PL 119-44).
Medicare Patient Access and Practice Stabilization Act of 2025
Client: AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION · Firm: FORBES-TATE
Issues related to Medicare and Medicaid payments to physicians; Issues related to medical imaging; Issues related to Appropriate Use Criteria (AUC); Issues related to prior authorization in Medicare and Medicaid; Issues related to H.R. 639 - Doctor Knows Best Act of 2025; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to Consolidated Appropriations Act, 2026 (PL 119-75); Issues related to SUPPORT for Patients and Communities Reauthorization Act of 2025 (PL 119-44); Issues related to H.R. 5737/S. 1692 - Radiology Outpatient Ordering Transmission (ROOT) Act.
Medicare Patient Access and Practice Stabilization Act of 2025
Client: AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION · Firm: FORBES-TATE
Issues related to Medicare and Medicaid payments to physicians; Issues related to medical imaging; Issues related to Appropriate Use Criteria (AUC); Issues related to prior authorization in Medicare and Medicaid; Issues related to H.R. 639 - Doctor Knows Best Act of 2025; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to S. 891 - Bipartisan Health Care Act; Issues related to H.R. 5737/S. 1692 - Radiology Outpatient Ordering Transmission (ROOT) Act.
Medicare Patient Access and Practice Stabilization Act of 2025
Client: AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION · Firm: FORBES-TATE
Issues related to the CY 2025 Medicare Physician Fee Schedule proposed rule; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to Consolidated Appropriations Act, 2026 (PL 119-75); Issues related to SUPPORT for Patients and Communities Reauthorization Act of 2025 (PL 119-44).
Medicare Patient Access and Practice Stabilization Act of 2025
Client: AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION · Firm: FORBES-TATE
Issues related to the CY 2025 Medicare Physician Fee Schedule proposed rule; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to Consolidated Appropriations Act, 2026 (PL 119-75); Issues related to SUPPORT for Patients and Communities Reauthorization Act of 2025 (PL 119-44).
Medicare Patient Access and Practice Stabilization Act of 2025
Client: AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION · Firm: FORBES-TATE
Issues related to Medicare and Medicaid payments to physicians; Issues related to medical imaging; Issues related to Appropriate Use Criteria (AUC); Issues related to prior authorization in Medicare and Medicaid; Issues related to H.R. 639 - Doctor Knows Best Act of 2025; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to S. 891 - Bipartisan Health Care Act; Issues related to H.R. 5737/S. 1692 - Radiology Outpatient Ordering Transmission (ROOT) Act.
Radiology Outpatient Ordering Transmission (ROOT) Act
Client: AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION · Firm: FORBES-TATE
Issues related to Medicare and Medicaid payments to physicians; Issues related to medical imaging; Issues related to Appropriate Use Criteria (AUC); Issues related to prior authorization in Medicare and Medicaid; Issues related to H.R. 639 - Doctor Knows Best Act of 2025; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to S. 891 - Bipartisan Health Care Act; Issues related to H.R. 5737/S. 1692 - Radiology Outpatient Ordering Transmission (ROOT) Act.
Radiology Outpatient Ordering Transmission (ROOT) Act
Client: AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION · Firm: FORBES-TATE
Issues related to Medicare and Medicaid payments to physicians; Issues related to medical imaging; Issues related to Appropriate Use Criteria (AUC); Issues related to prior authorization in Medicare and Medicaid; Issues related to H.R. 639 - Doctor Knows Best Act of 2025; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to S. 891 - Bipartisan Health Care Act; Issues related to H.R. 5737/S. 1692 - Radiology Outpatient Ordering Transmission (ROOT) Act.
Radiology Outpatient Ordering Transmission (ROOT) Act
Client: AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION · Firm: FORBES-TATE
Issues related to Medicare and Medicaid payments to physicians; Issues related to medical imaging; Issues related to Appropriate Use Criteria (AUC); Issues related to prior authorization in Medicare and Medicaid; Issues related to H.R. 639 - Doctor Knows Best Act of 2025; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to Consolidated Appropriations Act, 2026 (PL 119-75); Issues related to SUPPORT for Patients and Communities Reauthorization Act of 2025 (PL 119-44); Issues related to H.R. 5737/S. 1692 - Radiology Outpatient Ordering Transmission (ROOT) Act.
Issues related to the semiconductor industry; Issues related to trade; Issues related to manufacturing; Issues related to AI; Issues related to H.R. 5885/S. 3150 - GAIN AI Act of 2025.
Issues related to the semiconductor industry; Issues related to trade; Issues related to manufacturing; Issues related to AI; Issues related to H.R. 5885/S. 3150 - GAIN AI Act of 2025.
Issues related to the semiconductor industry; Issues related to trade; Issues related to manufacturing; Issues related to AI; Issues related to H.R. 5885/S. 3150 - GAIN AI Act of 2025.
Issues related to payments, including in H.R. 7035 / S. 3623 - Credit Card Competition Act of 2026; Issues related to the GENIUS Act (P.L. 119-27).
Issues related to payments, including in H.R. 7035 / S. 3623 - Credit Card Competition Act; Issues related to the GENIUS Act (P.L. 119-27).
Retirement Fairness for Charities and Educational Institutions Act of 2025
Client: INSURED RETIREMENT INSTITUTE · Firm: FORBES-TATE
Issues related to retirement savings; Issues related to H.R. 1013/S. 424 - The Retirement Fairness for Charities and Educational Institutions Act of 2025; Issues related to DOL Fiduciary rule.
Retirement Fairness for Charities and Educational Institutions Act of 2025
Client: INSURED RETIREMENT INSTITUTE · Firm: FORBES-TATE
Issues related to retirement savings; Issues related to H.R. 1013/S. 424 - The Retirement Fairness for Charities and Educational Institutions Act of 2025; Issues related to DOL Fiduciary rule.
Issues related to prescription drug pricing; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to pharmacy benefit managers; H.R. 1672 - Maintaining Investments in New Innovation Act; Issues related to the 340b program; Issues related to S. 832 - EPIC Act of 2025.
Issues related to prescription drug pricing; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to pharmacy benefit managers; H.R. 1672 - Maintaining Investments in New Innovation Act; Issues related to the 340b program; Issues related to S. 832 - EPIC Act of 2025.
Issues related to prescription drug pricing; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to pharmacy benefit managers; H.R. 1672 - Maintaining Investments in New Innovation Act; Issues related to the 340b program; Issues related to S. 832 - EPIC Act of 2025.
Bipartisan Health Care Act
Client: AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION · Firm: FORBES-TATE
Issues related to Medicare and Medicaid payments to physicians; Issues related to medical imaging; Issues related to Appropriate Use Criteria (AUC); Issues related to prior authorization in Medicare and Medicaid; Issues related to H.R. 639 - Doctor Knows Best Act of 2025; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to S. 891 - Bipartisan Health Care Act; Issues related to H.R. 5737/S. 1692 - Radiology Outpatient Ordering Transmission (ROOT) Act.
Bipartisan Health Care Act
Client: AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION · Firm: FORBES-TATE
Issues related to Medicare and Medicaid payments to physicians; Issues related to medical imaging; Issues related to Appropriate Use Criteria (AUC); Issues related to prior authorization in Medicare and Medicaid; Issues related to H.R. 639 - Doctor Knows Best Act of 2025; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to S. 891 - Bipartisan Health Care Act; Issues related to H.R. 5737/S. 1692 - Radiology Outpatient Ordering Transmission (ROOT) Act.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION · Firm: FORBES-TATE
Issues related to the Medicare Physician Fee Schedule and Authorized Use Criteria (AUC) in H.R. 1 - One Big Beautiful Bill Act.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: TRACTOR SUPPLY CO. · Firm: FORBES-TATE
H.R. 1 - One Big Beautiful Bill Act; Issues related to Tax Relief for American Families and Workers.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: TRACTOR SUPPLY CO. · Firm: FORBES-TATE
H.R. 1 - One Big Beautiful Bill Act; Issues related to Tax Relief for American Families and Workers.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: ELI LILLY AND COMPANY FKA LILLY USA, LLC · Firm: FORBES-TATE
Issues related to the report accompanying the FY 26 Senate Labor-HHS-Education Appropriations; Issues related to Rx drug pricing in H.R. 1 - the One Big Beautiful Bill Act.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: ALTRIA CLIENT SERVICES LLC · Firm: FORBES-TATE
Issues related to tobacco tax; Issues related to excise tax on tobacco in the Inflation Reduction Act of 2022 (PL 117-169); Issues related to drawback provision in H.R.1 - the One Big Beautiful Bill Act (PL 119-21).
Retirement Fairness for Charities and Educational Institutions Act of 2025
Client: INSURED RETIREMENT INSTITUTE · Firm: FORBES-TATE
Issues related to retirement savings; Issues related to H.R. 1013 - The Retirement Fairness for Charities and Educational Institutions Act of 2025; Issues related to DOL Fiduciary rule.
Retirement Fairness for Charities and Educational Institutions Act of 2025
Client: INSURED RETIREMENT INSTITUTE · Firm: FORBES-TATE
Issues related to retirement savings; Issues related to H.R. 1013/S. 424 - The Retirement Fairness for Charities and Educational Institutions Act of 2025; Issues related to DOL Fiduciary rule.
Retirement Fairness for Charities and Educational Institutions Act of 2025
Client: INSURED RETIREMENT INSTITUTE · Firm: FORBES-TATE
Issues related to retirement savings; Issues related to H.R. 1013/S. 424 - The Retirement Fairness for Charities and Educational Institutions Act of 2025; Issues related to DOL Fiduciary rule.
Freedom from Intimidation in Elections Act
Client: SHEIN TECHNOLOGY LLC · Firm: FORBES-TATE
Issues related to legislative and regulatory issues impacting the fashion and on-demand apparel industry, e-retailing and overall online competition, including trade related matters and sustainability; General education regarding SHEIN's presence, operating footprint, and economic impact in the United States; Issues related to trade provision in H.R. 8070, the Servicemember Quality of Life Improvement and National Defense Authorization Act for Fiscal Year 2025 and H.R. 10545, the American Relief Act of 2025; Issues related to de minimis reform.
Issues related to prescription drug pricing; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to pharmacy benefit managers; H.R. 1672 - Maintaining Investments in New Innovation Act; Issues related to the 340b program; Issues related to S. 832 - EPIC Act of 2025.
Issues related to prescription drug pricing; Issues related to Medicare, Medicaid, Cell and Gene Therapies; Issues regarding the 340B Drug Pricing Program; Issues related to the implementation of Consolidated Appropriations Act, 2024 (PL 118-42); Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); H.R. 1672 - Maintaining Investments in New Innovation Act.
Issues related to prescription drug pricing; Issues related to Medicare, Medicaid, Cell and Gene Therapies; Issues regarding the 340B Drug Pricing Program; Issues related to the implementation of Consolidated Appropriations Act, 2024 (PL 118-42); Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); H.R. 1672 - Maintaining Investments in New Innovation Act.
Issues related to prescription drug pricing; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to pharmacy benefit managers; H.R. 1672 - Maintaining Investments in New Innovation Act; Issues related to the 340b program; Issues related to S. 832 - EPIC Act of 2025.
Issues related to prescription drug pricing; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to pharmacy benefit managers; H.R. 1672 - Maintaining Investments in New Innovation Act; Issues related to the 340b program.
Issues related to prescription drug pricing; Issues related to Medicare, Medicaid, Cell and Gene Therapies; Issues regarding the 340B Drug Pricing Program; Issues related to the implementation of Consolidated Appropriations Act, 2024 (PL 118-42); Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); H.R. 1672 - Maintaining Investments in New Innovation Act.
Combating Organized Retail Crime Act of 2025
Client: ASSOCIATION OF AMERICAN RAILROADS · Firm: FORBES-TATE
Issues related to preserving economic balance regarding regulation of the railroad industry; Issues related to two-man crew sites; Issues related to infrastructure and transportation; Issues related to safety requirements for rail carriers and trains transporting hazardous materials; Issues related to H.R. 2853/S. 1404 - Combating Organized Retail Crime Act.
Combating Organized Retail Crime Act of 2025
Client: ASSOCIATION OF AMERICAN RAILROADS · Firm: FORBES-TATE
Issues related to preserving economic balance regarding regulation of the railroad industry; Issues related to 2-man crew site; Issues related to infrastructure and transportation; Issues related to safety requirements for rail carriers and trains transporting hazardous materials; Issues related to H.R. 2853/S. 1404 - Combating Organized Retail Crime Act.
Treat and Reduce Obesity Act of 2025
Client: ELI LILLY AND COMPANY FKA LILLY USA, LLC · Firm: FORBES-TATE
Issues regarding the Centers for Medicare and Medicaid Services National Coverage Decision (NCD) on Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer's Disease; Issues related to H.R. 4231/S. 1973 - Treat and Reduce Obesity Act of 2025; Issues related to H.R. 5316 - Drug Shortage Compounding Patient Access Act of 2025.
Treat and Reduce Obesity Act of 2025
Client: ELI LILLY AND COMPANY FKA LILLY USA, LLC · Firm: FORBES-TATE
Issues regarding the Centers for Medicare and Medicaid Services National Coverage Decision (NCD) on Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer's Disease; Issues related to H.R. 4231/S. 1973 - the Treat and Reduce Obesity Act of 2025; Issues related to H.R. 5316 - Drug Shortage Compounding Patient Access Act of 2025.
Drug Shortage Compounding Patient Access Act of 2025
Client: ELI LILLY AND COMPANY FKA LILLY USA, LLC · Firm: FORBES-TATE
Issues related to Insulin pricing; Issues related to the pricing of GLP-1 therapeutic products; Issues regarding the 340B Drug Pricing Program; Issues related to H.R. 5316 - Drug Shortage Compounding Patient Access Act of 2025; Issues related to H.R. 6509 - SAFE Drugs Act of 2025.
Drug Shortage Compounding Patient Access Act of 2025
Client: ELI LILLY AND COMPANY FKA LILLY USA, LLC · Firm: FORBES-TATE
Issues regarding the Centers for Medicare and Medicaid Services National Coverage Decision (NCD) on Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer's Disease; Issues related to H.R. 4231/S. 1973 - Treat and Reduce Obesity Act of 2025; Issues related to H.R. 5316 - Drug Shortage Compounding Patient Access Act of 2025.
Drug Shortage Compounding Patient Access Act of 2025
Client: ELI LILLY AND COMPANY FKA LILLY USA, LLC · Firm: FORBES-TATE
Issues regarding the Centers for Medicare and Medicaid Services National Coverage Decision (NCD) on Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer's Disease; Issues related to H.R. 4231/S. 1973 - the Treat and Reduce Obesity Act of 2025; Issues related to H.R. 5316 - Drug Shortage Compounding Patient Access Act of 2025.
Drug Shortage Compounding Patient Access Act of 2025
Client: ELI LILLY AND COMPANY FKA LILLY USA, LLC · Firm: FORBES-TATE
Issues related to Insulin pricing; Issues related to the pricing of GLP-1 therapeutic products; Issues regarding the 340B Drug Pricing Program; Issues related to H.R. 5316 - Drug Shortage Compounding Patient Access Act of 2025.
Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026
Client: AIRLINES FOR AMERICA · Firm: FORBES-TATE
Issues related to aviation system funding and management related to H.R.5371 - Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026 (PL 119-37); Issues related to aviation systemsoperations related to consideration of National Defense Authorization Act for Fiscal Year 2026 (PL 119-60).
Issues related to Medicare and Medicaid payments to physicians; Issues related to medical imaging; Issues related to Appropriate Use Criteria (AUC); Issues related to prior authorization in Medicare and Medicaid; Issues related to H.R. 639 - Doctor Knows Best Act of 2025; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to S. 891 - Bipartisan Health Care Act; Issues related to H.R. 5737/S. 1692 - Radiology Outpatient Ordering Transmission (ROOT) Act.
Issues related to the semiconductor industry; Issues related to trade; Issues related to manufacturing; Issues related to AI; Issues related to H.R. 5885 - GAIN AI Act of 2025.
Doctor Knows Best Act of 2025
Client: AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION · Firm: FORBES-TATE
Issues related to Medicare and Medicaid payments to physicians; Issues related to medical imaging; Issues related to Appropriate Use Criteria (AUC); Issues related to prior authorization in Medicare and Medicaid; Issues related to H.R. 639 - Doctor Knows Best Act of 2025; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to S. 891 - Bipartisan Health Care Act; Issues related to S. 1692 - Radiology Outpatient Ordering Transmission (ROOT) Act.
Doctor Knows Best Act of 2025
Client: AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION · Firm: FORBES-TATE
Issues related to Medicare and Medicaid payments to physicians; Issues related to medical imaging; Issues related to Appropriate Use Criteria (AUC); Issues related to prior authorization in Medicare and Medicaid; Issues related to H.R. 639 - Doctor Knows Best Act of 2025; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to S. 891 - Bipartisan Health Care Act; Issues related to H.R. 5737/S. 1692 - Radiology Outpatient Ordering Transmission (ROOT) Act.
Doctor Knows Best Act of 2025
Client: AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION · Firm: FORBES-TATE
Issues related to Medicare and Medicaid payments to physicians; Issues related to medical imaging; Issues related to Appropriate Use Criteria (AUC); Issues related to prior authorization in Medicare and Medicaid; Issues related to H.R. 639 - Doctor Knows Best Act of 2025; Issues related to H.R. 879 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to S. 891 - Bipartisan Health Care Act.
Doctor Knows Best Act of 2025
Client: AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION · Firm: FORBES-TATE
Issues related to Medicare and Medicaid payments to physicians; Issues related to medical imaging; Issues related to Appropriate Use Criteria (AUC); Issues related to prior authorization in Medicare and Medicaid; Issues related to H.R. 639 - Doctor Knows Best Act of 2025; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to S. 891 - Bipartisan Health Care Act; Issues related to S. 1692 - Radiology Outpatient Ordering Transmission (ROOT) Act.
Issues related to Insulin pricing; Issues related to the pricing of GLP-1 therapeutic products; Issues regarding the 340B Drug Pricing Program; Issues related to H.R. 5316 - Drug Shortage Compounding Patient Access Act of 2025; Issues related to H.R. 6509 - SAFE Drugs Act of 2025.
Issues related to advanced design tax credit; H.R. 802 - STAR Act of 2025; Issues related to implementation of the CHIPS and Science Act of 2022 (PL 117-167); Issues related to research and development tax amortization fix.
Issues related to advanced design tax credit; Issues related to H.R. 802 - STAR Act of 2025; Issues related to implementation of the CHIPS and Science Act of 2022 (PL 117-167); Issues related to research and development tax amortization fix.
Issues related to advanced design tax credit; H.R. 802 - STAR Act of 2025; Issues related to implementation of the CHIPS and Science Act of 2022 (PL 117-167); Issues related to research and development tax amortization fix.
Issues related to retirement security and savings matters; Issues related to small business retirement and retirement savings; Issues related to retirement savings for military spouses; SIMPLE IRAs; Issues related to financial transactions, capital gains, and dividend income taxes; Issues related to senior investor protection matters; Issues related to SEC and DOL standard of care rulemaking; Issues related to partnership tax and IRS Code Section 199A; Issues related to banking services.
Issues related to bank chartering.
Issues related to retirement security and savings matters; Issues related to small business retirement and retirement savings; Issues related to retirement savings for military spouses; SIMPLE IRAs; Issues related to financial transactions, capital gains, and dividend income taxes; Issues related to senior investor protection matters; Issues related to SEC and DOL standard of care rulemaking; Issues related to partnership tax and IRS Code Section 199A.
Filing targets: SENATE
2026 · third_quarter · Q3
Issues related to legislation governing regulation of prediction markets.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TYSON SHARED SERVICES, INC. via FORBES-TATE
2026 · third_quarter · Q3
Issues related to livestock and food pricing.
Issues related to workplace standards; Issues related to livestock and food pricing.
Issues related to workplace standards; Issues related to livestock and food pricing.
Issues related to workplace standards; Issues related to livestock and food pricing; Issues related to labor union work condition negotiation.
Issues related to Xylazine usage.
Issues related to workplace standards; Issues related to livestock and food pricing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
T-MOBILE via FORBES-TATE
2026 · third_quarter · Q3
Issues related to accelerated use of AMT credits; Issues related to the implementation of the Inflation Reduction Act of 2022 (P.L. 117-169); Issues related to the Research and Development Tax Credit; Issues related to expensing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VERIZON COMMUNICATIONS INC AND VARIOUS SUBSIDIARIES via FORBES-TATE
2026 · third_quarter · Q3
Issues related to accelerated depreciation; Issues related to infrastructure deployment; Issues related to Research and Development Tax Credit; Issues related to Tax Cuts and Jobs Act (PL 115-97) Extension.
Issues related to spectrum auctions, infrastructure deployment, privacy, and 5G deployment; Issues related to National Defense Authorization Act for Fiscal Year 2026 (PL 119-60).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TRACTOR SUPPLY CO. via FORBES-TATE
2026 · third_quarter · Q3
Issues related to tariffs and trade.
Issues related to federal land use.
Issues related to tariffs and trade.
Issues related to the One Big Beautiful Bill Act (PL 119-21); Issues related to Tax Relief for American Families and Workers; Issues related to H.R. 5099 - SAFES Act.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of, U.S. Trade Representative (USTR)
PELOTON INTERACTIVE, INC. via FORBES-TATE
2026 · third_quarter · Q3
Issues related to commerce, tax, trade and health.
Issues related to commerce, tax, trade and health.
Issues related to commerce, tax, trade and health.
PHRMA via FORBES-TATE
2026 · third_quarter · Q3
Issues pertaining to prescription drug pricing; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to pharmacy benefit managers; Issues related to the Medicaid Drug Rebate Program.
Issues related to data exclusivity under the United States Mexico Canada Agreement (USMCA); Issues regarding the World Trade Organization's TRIPS Waiver on COVID Vaccines; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the Medicaid Drug Rebate Program.
Issues pertaining to prescription drug pricing; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the Medicaid Drug Rebate Program.
NOVARTIS, INC. via FORBES-TATE
2026 · third_quarter · Q3
Issues related to prescription drug pricing; Issues related to pharmaceutical intellectual property; Issues related to international trade; Issues related to the 340b program.
Issues related to prescription drug pricing; Issues related to Medicare, Medicaid, Cell and Gene Therapies; Issues regarding the 340B Drug Pricing Program; Issues related to the implementation of Consolidated Appropriations Act, 2024 (PL 118-42); Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); H.R. 1672 - Maintaining Investments in New Innovation Act; Issues related to Most Favored Nation policy; H.R. 3037/S. 1500 - Access to Breast Cancer Diagnosis Act of 2025.
2026 · third_quarter · Q3
Issues related to prescription drug pricing; Issues related to Section 340B of the Public Health Service Act (PL 78-410); Drug pricing issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to flu and RSV vaccines.
Issues related to prescription drug pricing, including the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to Section 340B of the Public Health Service Act (PL 78-410); Issues related to pharmacy benefit managers.
Issues related to Orphan Drug Tax Credit; Issues related to the excise tax for the Vaccine Injury Compensation Fund.
RTX CORPORATION via FORBES-TATE
2026 · third_quarter · Q3
Issues related to Defense, Transportation, and Science Authorization & Appropriations; Issues related to FAA re-authorization.
Issues related to Defense, Transportation, and Science Authorization & Appropriations; Issues related to FAA re-authorization.
Issues related to Defense, Transportation, and Science Authorization & Appropriations; Issues related to FAA re-authorization.
JOBSOHIO via FORBES-TATE
2026 · third_quarter · Q3
Issues related to the implementation of the CHIPS and Science Act of 2022 (PL 117-167).
Issues related to economic development, job creation, job retention, job training, workforce development, and the retention of current business, and recruitment of new business to Ohio.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GENENTECH via FORBES-TATE
2026 · third_quarter · Q3
Issues related to international tax and R&D amortization credit in the Tax Cuts and Jobs Act (PL 115-97); Issues related to tax; Issues related to the implementation of the Tax Cuts and Jobs Act (PL 115-97); Issues related to the Medicaid Drug Rebate Program.
Issues related to funding of the strategic national stockpile; Issues related to the Tax Cuts and Jobs Act (PL 115-97); Issues related to the Medicaid Drug Rebate Program.
Issues regarding the Center for Medicare and Medicaid Innovation; Issues related to the implementation of the Tax Cuts and Jobs Act (PL 115-97); Issues related to the Medicaid Drug Rebate Program.
ALTRIA CLIENT SERVICES LLC via FORBES-TATE
2026 · third_quarter · Q3
Issues related to tobacco tax; Issues related to excise tax on tobacco in the Inflation Reduction Act of 2022 (PL 117-169); Issues related to drawback provision in H.R.1 - the One Big Beautiful Bill Act (PL 119-21).
Issues related to the International Trade Commission.
Issues related to flavors in Tobacco products; Conversations concerning federal appropriations policy related to FDA clarity on CBD; Issues related to unregulated vape products.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CTIA - THE WIRELESS ASSOCIATION via FORBES-TATE
2026 · third_quarter · Q3
Issues related to cybersecurity, spectrum legislation; Issues related to privacy; Issues related to supply chain.
Issues related to spectrum; Issues related to privacy; Issues related to supply chain; Issues related to spectrum in the National Defense Authorization Act for Fiscal Year 2026 (PL 119-60).
Issues related to privacy; Issues related to supply chain.
COALITION FOR CANNABIS POLICY, EDUCATION, AND REGULATION via FORBES-TATE
2026 · third_quarter · Q3
Issues pertaining to government-wide federal regulation of cannabis.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION OF AMERICAN RAILROADS via FORBES-TATE
2026 · third_quarter · Q3
Issues related to preserving economic balance regarding regulation of the railroad industry; Issues related to two-man crew sites; Issues related to infrastructure and transportation; Issues related to safety requirements for rail carriers and trains transporting hazardous materials; Issues related to H.R. 2853/S. 1404 - Combating Organized Retail Crime Act of 2025.
Issues related to the implementation of the Infrastructure Investment and Jobs Act (PL 117-58); Issues related to the implementation of the CHIPS Act (PL 117-167).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
AMGEN USA, INC. via FORBES-TATE
2026 · third_quarter · Q3
Issues related to Biosimilars; Issues related to drug pricing; Issues related to the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the Medicaid Drug Rebate Program; Issues related to the 340b program.
Issues related to prescription drug pricing; Issues related to drug pricing; Issues related to the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the Medicaid Drug Rebate Program; Issues related to the 340b program.
Issues related to the implementation of international tax and tax reform in the Tax Cuts and Jobs Act (PL 115-97); Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the Medicaid Drug Rebate Program; Issues related to the 340b program.
AMERICAN INDEPENDENT MEDICAL PRACTICE ASSOCIATION via FORBES-TATE
2026 · third_quarter · Q3
Issues related to healthcare; Issues related to provider reimbursement.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION via FORBES-TATE
2026 · third_quarter · Q3
Issues related to Medicare and Medicaid payments to physicians; Issues related to medical imaging; Issues related to Appropriate Use Criteria (AUC); Issues related to prior authorization in Medicare and Medicaid; Issues related to H.R. 639 - Doctor Knows Best Act of 2025; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to S. 891 - Bipartisan Health Care Act; Issues related to H.R. 5737/S. 1692 - Radiology Outpatient Ordering Transmission (ROOT) Act.
Issues related to surprise billing; Issues related to prior authorization in Medicare and Medicaid.
ALEXION PHARMACEUTICALS, INC. via FORBES-TATE
2026 · third_quarter · Q3
Issues related to healthcare, including drug pricing and Medicare Part D; Issues related to orphan drug tax credit; Issues related to rare disease; Issues related to the Inflation Reduction Act of 2022 (PL 117-169); Issues related to orphan drugs under the Drug Price Negotiation Program.
Issues related to healthcare, including drug pricing and Medicare Part D; Issues related to the Inflation Reduction Act of 2022 (PL 117-169).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AIRLINES FOR AMERICA via FORBES-TATE
2026 · third_quarter · Q3
Issues related to aviation system funding and management related to Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026 (PL 119-37); Issues related to aviation systemsoperations related to consideration of National Defense Authorization Act for Fiscal Year 2026 (PL 119-60).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ADVANCED MICRO DEVICES (AMD) via FORBES-TATE
2026 · third_quarter · Q3
Issues related to the semiconductor industry; Issues related to trade; Issues related to manufacturing; Issues related to implementation of the CHIPS and Science Act of 2022 (PL 117-167); Issues related to AI.
Issues related to advanced design tax credit; Issues related to H.R. 802 - STAR Act of 2025; Issues related to implementation of the CHIPS and Science Act of 2022 (PL 117-167); Issues related to research and development tax amortization fix.
Issues related to the semiconductor industry; Issues related to trade; Issues related to manufacturing; Issues related to implementation of the CHIPS and Science Act of 2022 (PL 117-167); Issues related to export controls.
NORTHPORT HEALTH SERVICES via FORBES-TATE
2026 · third_quarter · Q3
Healthcare legislative issues, including Medicare, Medicaid, and budget issues; Issues related to nursing home arbitration, group and concurrent therapy, and post-acute care reform.
Healthcare legislative issues, including Medicare, Medicaid, and budget issues; Issues related to nursing home arbitration, group and concurrent therapy, post-acute care reform, the Older Americans Act (PL 89-73), intergenerational therapy; Issues related to Medicare requirements for participation.
Healthcare legislative issues, including Medicare, Medicaid, and budget issues; Issues related to nursing home arbitration, group and concurrent therapy, and post-acute care reform.
MONUMENTAL SPORTS via FORBES-TATE
2026 · third_quarter · Q3
Issues related to sports.
Issues related to the funding of the District of Columbia.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
IRON MOUNTAIN INFORMATION MANAGEMENT, LLC via FORBES-TATE
2026 · third_quarter · Q3
Issues related to privacy and data security legislation related to consumer data breach notification; Issues related to data centers.
Issues related to federal records management; Issues related to House Transportation and Infrastructure Committee Resolution regarding Prospectus PPA-FBC-BO17; Issues related to federal record storage; Issues related to federal records management for the VA; Issues related to data centers.
Issues related to Department of Defense operations, including records management; Issues related to the implementation of the American Rescue Plan Act of 2021 (PL 117-2); Issues related to data centers.
2026 · third_quarter · Q3
Healthcare issues regarding oncology and early multi-cancer detection, including diagnostics and screening; Medicare issues regarding oncology and early multi-cancer detection, including diagnostics and screening.
Healthcare issues regarding oncology and early multi-cancer detection, including diagnostics and screening; Medicare issues regarding oncology and early multi-cancer detection, including diagnostics and screening.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · third_quarter · Q3
Issues pertaining to gig economy workers and related status.
Issues related to the Supplemental Nutrition Assistance Program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DIGESTIVE HEALTH PHYSICIANS ASSOCIATION via FORBES-TATE
2026 · third_quarter · Q3
Issues related to healthcare data; Issues related to provider reimbursement.
Issues related to Medicare Advantage; Issues related to physician payments.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UBER TECHNOLOGIES, INC. via FORBES-TATE
2026 · second_quarter · 2A
Issues related to transportation and food delivery.
Issues related to transportation and food delivery; Issues related to transportation bill reauthorization.
Issues related to transportation and food delivery.
2026 · second_quarter · Q2
Issues related to prescription drug pricing; Issues related to Section 340B of the Public Health Service Act (PL 78-410); Drug pricing issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to flu and RSV vaccines.
Issues related to prescription drug pricing, including the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to Section 340B of the Public Health Service Act (PL 78-410); Issues related to pharmacy benefit managers.
Issues related to orphan drug tax credit; Issues related to the excise tax for the Vaccine Injury Compensation Fund.
ASSOCIATION OF AMERICAN RAILROADS via FORBES-TATE
2026 · second_quarter · Q2
Issues related to preserving economic balance regarding regulation of the railroad industry; Issues related to two-man crew sites; Issues related to infrastructure and transportation; Issues related to safety requirements for rail carriers and trains transporting hazardous materials; Issues related to H.R. 2853/S. 1404 - Combating Organized Retail Crime Act.
Issues related to the implementation of the Infrastructure Investment and Jobs Act (PL 117-58); Issues related to the implementation of the CHIPS Act (PL 117-167).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
RTX CORPORATION via FORBES-TATE
2026 · second_quarter · Q2
Issues related to Defense, Transportation, and Science Authorization & Appropriations; Issues related to FAA re-authorization; Issues related to Energy and Water appropriations related to indirect costs.
Issues related to Defense, Transportation, and Science Authorization & Appropriations; Issues related to FAA re-authorization.
Issues related to Defense, Transportation, and Science Authorization & Appropriations; Issues related to FAA re-authorization.
AMGEN USA, INC. via FORBES-TATE
2026 · second_quarter · Q2
Issues related to the implementation of international tax and tax reform in the Tax Cuts and Jobs Act (PL 115-97); Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the Medicaid Drug Rebate Program; Issues related to the 340b program.
Issues related to Biosimilars; Issues related to drug pricing; Issues related to the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the Medicaid Drug Rebate Program; Issues related to the 340b program.
Issues related to the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the Medicaid Drug Rebate Program; Issues related to the 340b program.
INSURED RETIREMENT INSTITUTE via FORBES-TATE
2026 · second_quarter · Q2
Issues related to retirement savings; Issues related to H.R. 1013/S. 424 - The Retirement Fairness for Charities and Educational Institutions Act of 2025; Issues related to DOL Fiduciary rule.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TYSON SHARED SERVICES, INC. via FORBES-TATE
2026 · second_quarter · Q2
Issues related to workplace standards; Issues related to livestock and food pricing.
Issues related to workplace standards; Issues related to livestock and food pricing.
Issues related to Xylazine usage.
AMERICAN INDEPENDENT MEDICAL PRACTICE ASSOCIATION via FORBES-TATE
2026 · second_quarter · Q2
Issues related to healthcare; Issues related to provider reimbursement.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
T-MOBILE via FORBES-TATE
2026 · second_quarter · Q2
Issues related to accelerated use of AMT credits; Issues related to the implementation of the Inflation Reduction Act of 2022 (P.L. 117-169); Issues related to the Research and Development tax credit; Issues related to expensing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COALITION FOR CANNABIS POLICY, EDUCATION, AND REGULATION via FORBES-TATE
2026 · second_quarter · Q2
Issues pertaining to government-wide federal regulation of cannabis.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION via FORBES-TATE
2026 · second_quarter · Q2
Issues related to the CY 2025 Medicare Physician Fee Schedule proposed rule; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to Consolidated Appropriations Act, 2026 (PL 119-75); Issues related to SUPPORT for Patients and Communities Reauthorization Act of 2025 (PL 119-44).
Issues related to surprise billing; Issues related to prior authorization in Medicare and Medicaid.
Issues related to Medicare and Medicaid payments to physicians; Issues related to medical imaging; Issues related to Appropriate Use Criteria (AUC); Issues related to prior authorization in Medicare and Medicaid; Issues related to H.R. 639 - Doctor Knows Best Act of 2025; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to S. 891 - Bipartisan Health Care Act; Issues related to H.R. 5737/S. 1692 - Radiology Outpatient Ordering Transmission (ROOT) Act.
UBER TECHNOLOGIES, INC. via FORBES-TATE
2026 · second_quarter · Q2
Issues related to transportation and food delivery.
Issues related to transportation and food delivery.
Issues related to transportation and food delivery.
ALEXION PHARMACEUTICALS, INC. via FORBES-TATE
2026 · second_quarter · Q2
Issues related to healthcare, including drug pricing and Medicare Part D; Issues related to the Inflation Reduction Act of 2022 (PL 117-169).
Issues related to healthcare, including drug pricing and Medicare Part D; Issues related to orphan drug tax credit; Issues related to rare disease; Issues related to the Inflation Reduction Act of 2022 (PL 117-169); Issues related to orphan drugs under the Drug Price Negotiation Program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNIVERSAL MUSIC GROUP RECORDINGS, INC. via FORBES-TATE
2026 · second_quarter · Q2
Issues related to copyright and licensing; Issues related to artificial intelligence.
Issues related to copyright and licensing; Issues related to artificial intelligence; Issues related to creator rights.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AIRLINES FOR AMERICA via FORBES-TATE
2026 · second_quarter · Q2
Issues related to aviation system funding and management related to Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026 (PL 119-37); Issues related to aviation systemsoperations related to consideration of National Defense Authorization Act for Fiscal Year 2026 (PL 119-60).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
STRATHSPEY CROWN HOLDINGS, LLC via FORBES-TATE
2026 · second_quarter · Q2
Issues related to CMS coverage decisions and issues related to healthcare reform.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · second_quarter · Q2
Healthcare issues regarding oncology and early multi-cancer detection, including diagnostics and screening; Medicare issues regarding oncology and early multi-cancer detection, including diagnostics and screening.
Healthcare issues regarding oncology and early multi-cancer detection, including diagnostics and screening; Medicare issues regarding oncology and early multi-cancer detection, including diagnostics and screening.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · second_quarter · Q2
Issues pertaining to gig economy workers and related status.
Issues related to the Supplemental Nutrition Assistance Program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ADVANCED MICRO DEVICES (AMD) via FORBES-TATE
2026 · second_quarter · Q2
Issues related to the semiconductor industry; Issues related to trade; Issues related to manufacturing; Issues related to supply chain; Issues related to implementation of the CHIPS and Science Act of 2022 (PL 117-167).
Issues related to the semiconductor industry; Issues related to trade; Issues related to manufacturing; Issues related to implementation of the CHIPS and Science Act of 2022 (PL 117-167); Issues related to AI.
Issues related to the semiconductor industry; Issues related to trade; Issues related to manufacturing; Issues related to AI; Issues related to H.R. 5885/S. 3150 - GAIN AI Act of 2025.
EDWARD D. JONES & CO., L.P. via FORBES-TATE
2026 · second_quarter · Q2
Issues related to retirement security and savings matters; Issues related to small business retirement and retirement savings; Issues related to retirement savings for military spouses; SIMPLE IRAs; Issues related to financial transaction, capital gains, and dividend income taxes; Issues related to senior investor protection matters; Issues related to SEC and DOL standard of care rulemaking; Issues related to partnership tax and IRS Code Section 199A.
Issues related to bank chartering.
Issues related to retirement security and savings matters; Issues related to small business retirement and retirement savings; Issues related to retirement savings for military spouses; SIMPLE IRAs; Issues related to financial transaction, capital gains, and dividend income taxes; Issues related to senior investor protection matters; Issues related to SEC and DOL standard of care rulemaking; Issues related to partnership tax and IRS Code Section 199A; Issues related to banking services.
OPTIONS CLEARING CORPORATION (OCC) via FORBES-TATE
2026 · second_quarter · Q2
Issues related to financial services and tax.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ACTIVEHOURS INC., D/B/A EARNIN via FORBES-TATE
2026 · second_quarter · Q2
Issues related to banking and consumer protection legislation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
NORTHPORT HEALTH SERVICES via FORBES-TATE
2026 · second_quarter · Q2
Healthcare legislative issues, including Medicare, Medicaid, and budget issues; Issues related to nursing home arbitration, group and concurrent therapy, post-acute care reform, the Older Americans Act (PL 89-73), intergenerational therapy; Issues related to Medicare requirements for participation.
Healthcare legislative issues, including Medicare, Medicaid, and budget issues; Issues related to nursing home arbitration, group and concurrent therapy, and post-acute care reform.
Healthcare legislative issues, including Medicare, Medicaid, and budget issues; Issues related to nursing home arbitration, group and concurrent therapy, and post-acute care reform.
DIGESTIVE HEALTH PHYSICIANS ASSOCIATION via FORBES-TATE
2026 · second_quarter · Q2
Issues related to healthcare data; Issues related to provider reimbursement.
Issues related to Medicare Advantage; Issues related to physician payments.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CTIA - THE WIRELESS ASSOCIATION via FORBES-TATE
2026 · second_quarter · Q2
Issues related to cybersecurity, spectrum legislation; Issues related to privacy; Issues related to supply chain.
Issues related to broadband spectrum policy, 5G deployment, rural broadband, and privacy; Issues related to supply chain; Issues related to privacy.
Issues related to spectrum; Issues related to privacy; Issues related to supply chain; Issues related to spectrum in the National Defense Authorization Act for Fiscal Year 2026 (PL 119-60).
MONUMENTAL SPORTS via FORBES-TATE
2026 · second_quarter · Q2
Issues related to sports.
Issues related to the funding of the District of Columbia.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VISA U.S.A. INC. via FORBES-TATE
2026 · second_quarter · Q2
Issues related to payments, including in H.R. 7035 / S. 3623 - Credit Card Competition Act of 2026; Issues related to the GENIUS Act (P.L. 119-27).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VERIZON COMMUNICATIONS INC AND VARIOUS SUBSIDIARIES via FORBES-TATE
2026 · second_quarter · Q2
Issues related to spectrum auctions, infrastructure deployment, privacy, and 5G deployment. Issues related to National Defense Authorization Act for Fiscal Year 2026 (PL 119-60).
Issues related to accelerated depreciation; Issues related to infrastructure deployment; Issues related to Research and Development Tax Credit; Issues related to Tax Cuts and Jobs Act (PL 115-97) Extension.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TRACTOR SUPPLY CO. via FORBES-TATE
2026 · second_quarter · Q2
One Big Beautiful Bill Act (PL 119-21); Issues related to Tax Relief for American Families and Workers; Issues related to H.R. 5099 - SAFES Act.
Issues related to federal land use.
Issues related to tariffs and trade.
PHRMA via FORBES-TATE
2026 · second_quarter · Q2
Issues pertaining to prescription drug pricing; Medicare Part D; Importation of drugs; Issues related to 340b; Issues related to Drug Price Competition and Patent Term Restoration Act (PL 98-417); Issues related to Section 340B of the Public Health Service Act; Issues related to Consolidated Appropriations Act, 2022 (PL 117-103); Issues related to prescription drug user fee agreement; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the Medicaid Drug Rebate Program; Issues related to pharmacy benefit managers.
Issues pertaining to prescription drug pricing; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to pharmacy benefit managers; Issues related to the Medicaid Drug Rebate Program.
PELOTON INTERACTIVE, INC. via FORBES-TATE
2026 · second_quarter · Q2
Issues related to commerce, tax, trade and health.
Issues related to commerce, tax, trade and health.
Issues related to commerce, tax, trade and health.
NOVARTIS, INC. via FORBES-TATE
2026 · second_quarter · Q2
Issues related to prescription drug pricing; Issues related to Medicare, Medicaid, Cell and Gene Therapies; Issues regarding the 340B Drug Pricing Program; Issues related to the implementation of Consolidated Appropriations Act, 2024 (PL 118-42); Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); H.R. 1672 - Maintaining Investments in New Innovation Act; Issues related to Most Favored Nation policy; H.R. 3037 / S. 1500 Access to Breast Cancer Diagnosis Act of 2025.
Issues related to implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the 340b program.
IRON MOUNTAIN INFORMATION MANAGEMENT, LLC via FORBES-TATE
2026 · second_quarter · Q2
Issues related to Department of Defense operations, including records management; Issues related to the implementation of the American Rescue Plan Act of 2021 (PL 117-2).
Issues related to privacy and data security legislation related to consumer data breach notification.
Issues related to consolidation of federal data centers under the Federal Information Technology Acquisition and Reform Act (PL 113-291); Issues related to federal records management for the VA.
JOBSOHIO via FORBES-TATE
2026 · second_quarter · Q2
Issues related to the implementation of the CHIPS and Science Act of 2022 (PL 117-167).
Issues related to economic development, job creation, job retention, job training, workforce development, and the retention of current business, and recruitment of new business to Ohio.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GENENTECH via FORBES-TATE
2026 · second_quarter · Q2
Issues related to Medicare and Medicaid coverage and reimbursement; Issues pertaining to 340B; Issues related to drug importation; Issues related to prescription drug pricing; Issues related to the International Pricing Index for Medicare Part D; Issues related to prescription drug user fee agreement; Issues related to the implementation of the Tax Cuts and Jobs Act (PL 115-97); Issues related to pharmacy benefit managers; Issues related to the Medicaid Drug Rebate Program.
Issues related to the 340B Drug Pricing Program.
Intellectual property and process patent related issues.
ALTRIA CLIENT SERVICES LLC via FORBES-TATE
2026 · second_quarter · Q2
Issues related to the International Trade Commission.
Issues related to flavors in Tobacco products; Conversations concerning federal appropriations policy related to FDA clarity on CBD; Issues related to unregulated vape products.
Issues related to tobacco tax; Issues related to excise tax on tobacco in the Inflation Reduction Act of 2022 (PL 117-169); Issues related to drawback provision in H.R.1 - the One Big Beautiful Bill Act (PL 119-21).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VISA U.S.A. INC. via FORBES-TATE
2026 · first_quarter · 1A
Issues related to payments, including in H.R. 7035 / S. 3623 - Credit Card Competition Act; Issues related to the GENIUS Act (P.L. 119-27).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VISA U.S.A. INC. via FORBES-TATE
2026 · first_quarter · Q1
Issues relating to payments, including the Credit Card Competition Act; Issues related to the GENIUS Act (P.L. 119-27).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VERIZON COMMUNICATIONS INC AND VARIOUS SUBSIDIARIES via FORBES-TATE
2026 · first_quarter · Q1
Issues related to spectrum auctions, infrastructure deployment, privacy, and 5G deployment. Issues related to National Defense Authorization Act for Fiscal Year 2026 (PL 119-60).
Issues related to accelerated depreciation; Issues related to infrastructure deployment; Issues related to Research and Development Tax Credit; Issues related to Tax Cuts and Jobs Act (PL 115-97) Extension.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNIVERSAL MUSIC GROUP RECORDINGS, INC. via FORBES-TATE
2026 · first_quarter · Q1
Issues related to copyright and licensing; Issues related to artificial intelligence.
Issues related to copyright and licensing; Issues related to artificial intelligence; Issues related to creator rights.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UBER TECHNOLOGIES, INC. via FORBES-TATE
2026 · first_quarter · Q1
Issues related to transportation and food delivery; Issues related to transportation bill reauthorization.
Issues related to transportation and food delivery.
Issues related to transportation and food delivery.
TYSON SHARED SERVICES, INC. via FORBES-TATE
2026 · first_quarter · Q1
Issues related to Xylazine usage.
Issues related to workplace standards; Issues related to livestock and food pricing.
Issues related to workplace standards; Issues related to livestock and food pricing.
T-MOBILE via FORBES-TATE
2026 · first_quarter · Q1
Issues related to accelerated use of AMT credits; Issues related to the implementation of the Inflation Reduction Act of 2022 (P.L. 117-169); Issues related to the Research and Development tax credit; Issues related to expensing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
STRATHSPEY CROWN HOLDINGS, LLC via FORBES-TATE
2026 · first_quarter · Q1
Issues related to CMS coverage decisions and issues related to healthcare reform.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SONY INTERACTIVE ENTERTAINMENT LLC via FORBES-TATE
2026 · first_quarter · Q1
Issues related to gaming-related tariff policies.
Issues related to antitrust, competition, and the gaming industry.
Issues related to operational improvements for legislation related to issues involving online safety and accountability.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · first_quarter · Q1
Issues related to orphan drug tax credit; Issues related to the excise tax for the Vaccine Injury Compensation Fund.
Issues related to prescription drug pricing; Issues related to Section 340B of the Public Health Service Act (P.L. 78-410); Drug pricing issues related to the implementation of the Inflation Reduction Act of 2022 (P.L. 117-169); Issues related to flu and RSV vaccines.
Issues related to prescription drug pricing, including the implementation of the Inflation Reduction Act of 2022 (P.L. 117-169); Issues related to Section 340B of the Public Health Service Act (P.L. 78-410); Issues related to pharmacy benefit managers.
RTX CORPORATION via FORBES-TATE
2026 · first_quarter · Q1
Issues related to Defense, Transportation, and Science Authorization & Appropriations; Issues related to FAA re-authorization; Issues related to Energy and Water appropriations related to indirect costs.
Issues related to Defense, Transportation, and Science Authorization & Appropriations; Issues related to FAA re-authorization.
Issues related to Defense, Transportation, and Science Authorization & Appropriations; Issues related to FAA re-authorization.
OPTIONS CLEARING CORPORATION (OCC) via FORBES-TATE
2026 · first_quarter · Q1
Issues related to financial services and tax.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NORTHPORT HEALTH SERVICES via FORBES-TATE
2026 · first_quarter · Q1
Healthcare legislative issues, including Medicare, Medicaid, and budget issues; Issues related to nursing home arbitration, group and concurrent therapy, and post-acute care reform.
Healthcare legislative issues, including Medicare, Medicaid, and budget issues; Issues related to nursing home arbitration, group and concurrent therapy, post-acute care reform, the Older Americans Act (PL 89-73), intergenerational therapy; Issues related to Medicare requirements for participation.
Healthcare legislative issues, including Medicare, Medicaid, and budget issues; Issues related to nursing home arbitration, group and concurrent therapy, and post-acute care reform.
MONUMENTAL SPORTS via FORBES-TATE
2026 · first_quarter · Q1
Issues related to the funding of the District of Columbia.
Issues related to sports.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
IRON MOUNTAIN INFORMATION MANAGEMENT, LLC via FORBES-TATE
2026 · first_quarter · Q1
Issues related to consolidation of federal data centers under the Federal Information Technology Acquisition and Reform Act (PL 113-291); Issues related to federal records management for the VA.
Issues related to privacy and data security legislation related to consumer data breach notification.
Issues related to tax treatment of REITS (Real Estate Investment Trust).
INSURED RETIREMENT INSTITUTE via FORBES-TATE
2026 · first_quarter · Q1
Issues related to retirement savings; Issues related to H.R. 1013/S. 424 - The Retirement Fairness for Charities and Educational Institutions Act of 2025; Issues related to DOL Fiduciary rule.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HALOZYME THERAPEUTICS, INC. via FORBES-TATE
2026 · first_quarter · Q1
Issues related to biopharmaceutical research, development, and manufacturing.
Issues related to coverage and reimbursement.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2026 · first_quarter · Q1
Healthcare issues regarding oncology and early multi-cancer detection, including diagnostics and screening; Medicare issues regarding oncology and early multi-cancer detection, including diagnostics and screening.
Healthcare issues regarding oncology and early multi-cancer detection, including diagnostics and screening; Medicare issues regarding oncology and early multi-cancer detection, including diagnostics and screening.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · first_quarter · Q1
Issues pertaining to gig economy workers and related status.
Issues related to the Supplemental Nutrition Assistance Program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TRACTOR SUPPLY CO. via FORBES-TATE
2026 · first_quarter · Q1
Issues related to tariffs and trade.
Issues related to tariffs and trade.
Issues related to federal land use.
PHRMA via FORBES-TATE
2026 · first_quarter · Q1
Issues related to Direct to Consumer (DTC) Advertising; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the Medicaid Drug Rebate Program.
Issues related to data exclusivity under the United States Mexico Canada Agreement (USMCA); Issues regarding the World Trade Organization's TRIPS Waiver on COVID Vaccines; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the Medicaid Drug Rebate Program.
Issues pertaining to prescription drug pricing; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to pharmacy benefit managers; Issues related to the Medicaid Drug Rebate Program.
PELOTON INTERACTIVE, INC. via FORBES-TATE
2026 · first_quarter · Q1
Issues related to commerce, tax, trade and health.
Issues related to commerce, tax, trade and health.
Issues related to commerce, tax, trade and health.
NOVARTIS, INC. via FORBES-TATE
2026 · first_quarter · Q1
Issues related to prescription drug pricing and Intellectual Property (IP); Issues regarding the World Trade Organization's TRIPS Waiver on COVID Vaccines; Issues related to the 340b program.
Issues related to implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the 340b program.
Issues related to prescription drug pricing; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to pharmacy benefit managers; H.R. 1672 - Maintaining Investments in New Innovation Act; Issues related to the 340b program; Issues related to S. 832 - EPIC Act of 2025.
JOBSOHIO via FORBES-TATE
2026 · first_quarter · Q1
Issues related to the implementation of the CHIPS and Science Act of 2022 (PL 117-167).
Issues related to economic development, job creation, job retention, job training, workforce development, and the retention of current business, and recruitment of new business to Ohio.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GENENTECH via FORBES-TATE
2026 · first_quarter · Q1
Issues related to the 340B Drug Pricing Program.
Issues related to international tax and R&D amortization credit in the Tax Cuts and Jobs Act (PL 115-97); Issues related to tax; Issues related to the implementation of the Tax Cuts and Jobs Act (PL 115-97); Issues related to the Medicaid Drug Rebate Program.
Issues related to Medicare and Medicaid coverage and reimbursement; Issues pertaining to 340B; Issues related to drug importation; Issues related to prescription drug pricing; Issues related to the International Pricing Index for Medicare Part D; Issues related to prescription drug user fee agreement; Issues related to the implementation of the Tax Cuts and Jobs Act (PL 115-97); Issues related to pharmacy benefit managers; Issues related to the Medicaid Drug Rebate Program.
ALTRIA CLIENT SERVICES LLC via FORBES-TATE
2026 · first_quarter · Q1
Issues related to flavors in Tobacco products; Conversations concerning federal appropriations policy related to FDA clarity on CBD; Issues related to unregulated vape products.
Issues related to tobacco tax; Issues related to excise tax on tobacco in the Inflation Reduction Act of 2022 (PL 117-169); Issues related to drawback provision in H.R.1 - the One Big Beautiful Bill Act (PL 119-21).
Issues related to the International Trade Commission.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALEXION PHARMACEUTICALS, INC. via FORBES-TATE
2026 · first_quarter · Q1
Issues related to healthcare, including drug pricing and Medicare Part D; Issues related to the Inflation Reduction Act of 2022 (PL 117-169).
Issues related to healthcare, including drug pricing and Medicare Part D; Issues related to orphan drug tax credit; Issues related to rare disease; Issues related to the Inflation Reduction Act of 2022 (PL 117-169); Issues related to orphan drugs under the Drug Price Negotiation Program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EDWARD D. JONES & CO., L.P. via FORBES-TATE
2026 · first_quarter · Q1
Issues related to bank chartering.
Issues related to retirement security and savings matters; Issues related to small business retirement and retirement savings; Issues related to retirement savings for military spouses; SIMPLE IRAs; Issues related to financial transaction, capital gains, and dividend income taxes; Issues related to senior investor protection matters; Issues related to SEC and DOL standard of care rulemaking; Issues related to partnership tax and IRS Code Section 199A; Issues related to banking services.
Issues related to retirement security and savings matters; Issues related to small business retirement and retirement savings; Issues related to retirement savings for military spouses; SIMPLE IRAs; Issues related to financial transaction, capital gains, and dividend income taxes; Issues related to senior investor protection matters; Issues related to SEC and DOL standard of care rulemaking; Issues related to partnership tax and IRS Code Section 199A; Issues related to state and local tax provisions for Service Business in the One Big Beautiful Bill Act (PL 119-21).
DIGESTIVE HEALTH PHYSICIANS ASSOCIATION via FORBES-TATE
2026 · first_quarter · Q1
Issues related to Medicare Advantage; Issues related to physician payments.
Issues related to healthcare data; Issues related to provider reimbursement.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CTIA - THE WIRELESS ASSOCIATION via FORBES-TATE
2026 · first_quarter · Q1
Issues related to broadband spectrum policy, 5G deployment, rural broadband, and privacy; Issues related to supply chain; Issues related to privacy.
Issues related to cybersecurity, spectrum legislation; Issues related to privacy; Issues related to supply chain.
Issues related to spectrum; Issues related to privacy; Issues related to supply chain; Issues related to spectrum in the National Defense Authorization Act for Fiscal Year 2026 (PL 119-60).
COALITION FOR CANNABIS POLICY, EDUCATION, AND REGULATION via FORBES-TATE
2026 · first_quarter · Q1
Issues pertaining to government-wide federal regulation of cannabis.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMGEN USA, INC. via FORBES-TATE
2026 · first_quarter · Q1
Issues related to the implementation of international tax and tax reform in the Tax Cuts and Jobs Act (PL 115-97); Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the Medicaid Drug Rebate Program; Issues related to the 340b program.
Issues related to prescription drug pricing; Issues related to drug pricing; Issues related to the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the Medicaid Drug Rebate Program; Issues related to the 340b program.
Issues related to Biosimilars; Issues related to drug pricing; Issues related to the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the Medicaid Drug Rebate Program; Issues related to the 340b program.
AMERICAN INDEPENDENT MEDICAL PRACTICE ASSOCIATION via FORBES-TATE
2026 · first_quarter · Q1
Issues related to healthcare; Issues related to provider reimbursement.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION via FORBES-TATE
2026 · first_quarter · Q1
Issues related to the CY 2025 Medicare Physician Fee Schedule proposed rule; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to Consolidated Appropriations Act, 2026 (PL 119-75); Issues related to SUPPORT for Patients and Communities Reauthorization Act of 2025 (PL 119-44).
Issues related to surprise billing; Issues related to prior authorization in Medicare and Medicaid.
Issues related to Medicare and Medicaid payments to physicians; Issues related to medical imaging; Issues related to Appropriate Use Criteria (AUC); Issues related to prior authorization in Medicare and Medicaid; Issues related to H.R. 639 - Doctor Knows Best Act of 2025; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to Consolidated Appropriations Act, 2026 (PL 119-75); Issues related to SUPPORT for Patients and Communities Reauthorization Act of 2025 (PL 119-44); Issues related to H.R. 5737/S. 1692 - Radiology Outpatient Ordering Transmission (ROOT) Act.
AIRLINES FOR AMERICA via FORBES-TATE
2026 · first_quarter · Q1
Issues related to aviation system funding and management related to Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026 (PL 119-37); Issues related to aviation systemsoperations related to consideration of National Defense Authorization Act for Fiscal Year 2026 (PL 119-60).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to commerce, tax, trade and health.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE
Issues related to Direct to Consumer (DTC) Advertising; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the Medicaid Drug Rebate Program.
Issues pertaining to prescription drug pricing; Medicare Part D; Importation of drugs; Issues related to 340b; Issues related to Drug Price Competition and Patent Term Restoration Act (PL 98-417); Issues related to Section 340B of the Public Health Service Act; Issues related to Consolidated Appropriations Act, 2022 (PL 117-103); Issues related to prescription drug user fee agreement; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the Medicaid Drug Rebate Program; Issues related to pharmacy benefit managers.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to prescription drug pricing and Intellectual Property (IP); Issues regarding the World Trade Organization's TRIPS Waiver on COVID Vaccines; Issues related to the 340b program.
Issues related to prescription drug pricing; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the 340b program.
Issues related to implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the 340b program.
Issues related to prescription drug pricing; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to pharmacy benefit managers; H.R. 1672 - Maintaining Investments in New Innovation Act; Issues related to the 340b program; Issues related to S. 832 - EPIC Act of 2025.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to Defense, Transportation, and Science Authorization & Appropriations; Issues related to FAA re-authorization.
Filing targets: Energy, Dept of, HOUSE OF REPRESENTATIVES, SENATE
Issues related to intellectual property and process patent.
Issues related to Medicare and Medicaid coverage and reimbursement; Issues related to 340B; Issues related to drug importation; Issues related to prescription drug pricing; Issues related to the International Pricing Index for Medicare Part D; Issues related to prescription drug user fee agreement; Issues related to the implementation of the Tax Cuts and Jobs Act (PL 115-97); Issues related to pharmacy benefit managers; Issues related to the Medicaid Drug Rebate Program.
Issues related to the 340B Drug Pricing Program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to broadband spectrum policy, 5G deployment, rural broadband, and privacy; Issues related to supply chain; Issues related to privacy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the Medicaid Drug Rebate Program; Issues related to the 340b program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to the CY 2025 Medicare Physician Fee Schedule proposed rule; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to Consolidated Appropriations Act, 2026 (PL 119-75); Issues related to SUPPORT for Patients and Communities Reauthorization Act of 2025 (PL 119-44).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to the semiconductor industry; Issues related to trade; Issues related to manufacturing; Issues related to supply chain; Issues related to implementation of the CHIPS and Science Act of 2022 (PL 117-167).
Issues related to the semiconductor industry; Issues related to trade; Issues related to manufacturing; Issues related to AI; Issues related to H.R. 5885/S. 3150 - GAIN AI Act of 2025.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to consolidation of federal data centers under the Federal Information Technology Acquisition and Reform Act (PL 113-291); Issues related to federal records management for the VA; Issues related to data centers.
Issues related to tax treatment of REITS (Real Estate Investment Trust); Issues related to data centers.
Issues related to federal records management; Issues related to federal background checks; Issues related to data centers.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to transportation and food delivery.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to Defense, Transportation, and Science Authorization & Appropriations; Issues related to FAA re-authorization.
Filing targets: Energy, Dept of, HOUSE OF REPRESENTATIVES, SENATE
Issues related to prescription drug pricing; Issues related to drug pricing; Issues related to the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the Medicaid Drug Rebate Program; Issues related to the 340b program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to livestock and food pricing.
Issues related to workplace standards; Issues related to livestock and food pricing; Issues related to labor union work condition negotiation.
Issues related to workplace standards; Issues related to livestock and food pricing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to transportation and food delivery; Issues related to transportation bill reauthorization.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to the semiconductor industry; Issues related to trade; Issues related to manufacturing; Issues related to implementation of the CHIPS and Science Act of 2022 (PL 117-167); Issues related to export controls.
Issues related to advanced design tax credit; Issues related to H.R. 802 - STAR Act of 2025; Issues related to implementation of the CHIPS and Science Act of 2022 (PL 117-167); Issues related to research and development tax amortization fix.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE
Issues related to retirement security and savings matters; Issues related to small business retirement and retirement savings; Issues related to retirement savings for military spouses; SIMPLE IRAs; Issues related to financial transaction, capital gains, and dividend income taxes; Issues related to senior investor protection matters; Issues related to SEC and DOL standard of care rulemaking; Issues related to partnership tax and IRS Code Section 199A; Issues related to state and local tax provisions for Service Business in the One Big Beautiful Bill Act (PL 119-21).
Filing targets: SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to privacy; Issues related to supply chain.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to tariffs and trade.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of, U.S. Trade Representative (USTR)
Issues related to data exclusivity under the United States Mexico Canada Agreement (USMCA); Issues regarding the World Trade Organization's TRIPS Waiver on COVID Vaccines; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the Medicaid Drug Rebate Program.
Issues pertaining to prescription drug pricing; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the Medicaid Drug Rebate Program.
Issues related to Direct to Consumer (DTC) Advertising; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the Medicaid Drug Rebate Program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to commerce, tax, trade and health.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE
Issues related to prescription drug pricing; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the 340b program.
Issues related to prescription drug pricing; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to pharmacy benefit managers; H.R. 1672 - Maintaining Investments in New Innovation Act; Issues related to the 340b program; Issues related to S. 832 - EPIC Act of 2025.
Issues related to prescription drug pricing and Intellectual Property (IP); Issues regarding the World Trade Organization's TRIPS Waiver on COVID Vaccines; Issues related to the 340b program.
Issues related to prescription drug pricing; Issues related to pharmaceutical intellectual property; Issues related to international trade; Issues related to the 340b program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to tax treatment of REITS (Real Estate Investment Trust).
Issues related to federal records management; Issues related to House Transportation and Infrastructure Committee Resolution regarding Prospectus PPA-FBC-BO17; Issues related to federal record storage; Issues related to federal records management for the VA.
Issues related to federal records management; Issues related to federal background checks.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to funding of the strategic national stockpile; Issues related to the Tax Cuts and Jobs Act (PL 115-97); Issues related to the Medicaid Drug Rebate Program.
Issues related to international tax and R&D amortization credit in the Tax Cuts and Jobs Act (PL 115-97); Issues related to tax; Issues related to the implementation of the Tax Cuts and Jobs Act (PL 115-97); Issues related to the Medicaid Drug Rebate Program.
Issues regarding the Center for Medicare and Medicaid Innovation; Issues related to the implementation of the Tax Cuts and Jobs Act (PL 115-97); Issues related to the Medicaid Drug Rebate Program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to transportation and food delivery.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to workplace standards; Issues related to livestock and food pricing.
Issues related to livestock and food pricing.
Issues related to workplace standards; Issues related to livestock and food pricing; Issues related to labor union work condition negotiation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to Defense, Transportation, and Science Authorization & Appropriations; Issues related to FAA re-authorization.
Filing targets: Energy, Dept of, HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to Department of Defense operations, including records management; Issues related to the implementation of the American Rescue Plan Act of 2021 (PL 117-2).
Issues related to federal records management; Issues related to House Transportation and Infrastructure Committee Resolution regarding Prospectus PPA-FBC-BO17; Issues related to federal record storage; Issues related to federal records management for the VA.
Issues related to federal records management; Issues related to federal background checks.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
One Big Beautiful Bill Act (PL 119-21); Issues related to Tax Relief for American Families and Workers.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of, U.S. Trade Representative (USTR)
Issues pertaining to prescription drug pricing; Medicare Part D; Importation of drugs; Issues related to 340b; Issues related to Drug Price Competition and Patent Term Restoration Act (PL 98-417); Issues related to Section 340B of the Public Health Service Act; Issues related to Consolidated Appropriations Act, 2022 (PL 117-103); Issues related to prescription drug user fee agreement; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the Medicaid Drug Rebate Program; Issues related to pharmacy benefit managers.
Issues pertaining to prescription drug pricing; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the Medicaid Drug Rebate Program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to commerce, tax, trade and health.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE
Issues related to prescription drug pricing; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the 340b program.
Issues related to prescription drug pricing; Issues related to pharmaceutical intellectual property; Issues related to international trade; Issues related to the 340b program.
Issues related to prescription drug pricing; Issues related to Medicare, Medicaid, Cell and Gene Therapies; Issues regarding the 340B Drug Pricing Program; Issues related to the implementation of Consolidated Appropriations Act, 2024 (PL 118-42); Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); H.R. 1672 - Maintaining Investments in New Innovation Act; Issues related to Most Favored Nation policy; H.R. 3037 / S. 1500 Access to Breast Cancer Diagnostic Act of 2025.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues regarding the Center for Medicare and Medicaid Innovation; Issues related to the implementation of the Tax Cuts and Jobs Act (PL 115-97); Issues related to the Medicaid Drug Rebate Program.
Intellectual property and process patent related issues.
Issues related to funding of the strategic national stockpile; Issues related to the Tax Cuts and Jobs Act (PL 115-97); Issues related to the Medicaid Drug Rebate Program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to retirement security and savings matters; Issues related to small business retirement and retirement savings; Issues related to retirement savings for military spouses; SIMPLE IRAs; Issues related to financial transaction, capital gains, and dividend income taxes; Issues related to senior investor protection matters; Issues related to SEC and DOL standard of care rulemaking; Issues related to partnership tax and IRS Code Section 199A.
Filing targets: SENATE
Issues related to privacy; Issues related to supply chain.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the Medicaid Drug Rebate Program; Issues related to the 340b program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE